Dynavax GmbH
dynavax.com
Vaccines
Biotechnology
Health Care
As featured in
Claim pageClaim
Follow
Overview
News
Salaries
Products
People
Growth
Offices
Financials
News
Dynavax Technologies stock trades near its 52-week high
Dynavax Technologies stock carried a USD 1,820,087,035 market cap on February 11, 2026. Volume reached 5,659,539 shares, 79.0 percent above average.
Read more
Report
Dynavax President and COO Sells 114,000 Shares on Sanofi Acquisition News
This vaccine-focused biotech reported a significant insider sale as it advances its hepatitis B franchise and global partnerships.
Read more
Report
Dynavax President and COO Sells 114,000 Shares on Sanofi Acquisition News
This vaccine-focused biotech reported a significant insider sale as it advances its hepatitis B franchise and global partnerships.
Read more
Report
Dynavax Says Investigational Shingles Vaccine At Par With GSK's Vaccine In Early-Stage Study
Read more
Report
Report
Report
Offices
Where the company hires and what each office is for
Cities
1
Hiring now
0
Countries
1
Berkeley
United States
HQ
200-500 est. staff
Financials
Total raised
$1M
Latest round
Grant
Funding rounds
1
Funding rounds
| Round | Announced | Amount | |
|---|---|---|---|
| Grant | 2016 | $1M | Details |